TGF-β 信号转导与前列腺肿瘤发生中的免疫
TGF-beta signalling and immunity in prostate tumourigenesis.
机构信息
Hanson Institute, Experimental Therapeutics Laboratory, Adelaide, SA 5000, Australia.
出版信息
Expert Opin Ther Targets. 2010 Feb;14(2):179-92. doi: 10.1517/14728220903544507.
IMPORTANCE OF THE FIELD
The TGF-beta's are pleiotropic cytokines that regulate multiple cellular functions. Their role in the prostate is important for normal prostate development and also in prostate tumourigenesis.
AREAS COVERED IN THIS REVIEW
The interactions TGF-beta-mediated signalling has with maintaining prostate health, as well as its role in prostate tumourigenesis and prostate tumour immune evasion, with emphasis on how a breakdown in these interactions may influence disease progression.
WHAT THE READER WILL GAIN
That TGF-beta influences normal prostate growth and differentiation by regulating the balance between epithelial cell proliferation and apoptosis, and involving the androgen receptor pathway. That TGF-beta protects and maintains prostate stem cells and a review of the contrasting role TGF-beta has in prostate tumourigenesis and tumour development, where TGF-beta acts as a tumour suppressor and then switches roles to become a tumour promoter, and creates a local immunosuppressive niche leading to systemic tumour tolerance.
TAKE HOME MESSAGE
TGF-beta signalling in prostate cancer is a valid target for the treatment of this disease; however any therapeutic regimen will require an understanding of all aspects of the TGF-beta-signalling nexus, otherwise by the very pleiotrophic nature of TGF-beta, limited clinical benefits may result.
重要性的领域
转化生长因子-β是一种多功能细胞因子,调节多种细胞功能。它们在前列腺中的作用对于正常前列腺的发育和前列腺肿瘤的发生都很重要。
这篇综述涵盖了转化生长因子-β介导的信号转导在维持前列腺健康中的作用,以及在前列腺肿瘤发生和前列腺肿瘤免疫逃逸中的作用,重点介绍了这些相互作用的破坏如何影响疾病的进展。
读者将获得什么
转化生长因子-β通过调节上皮细胞增殖和凋亡之间的平衡,以及涉及雄激素受体途径,影响正常前列腺的生长和分化。转化生长因子-β保护和维持前列腺干细胞,并回顾转化生长因子-β在前列腺肿瘤发生和肿瘤发展中的相反作用,其中转化生长因子-β作为肿瘤抑制因子,然后转变为肿瘤促进因子,并在局部产生免疫抑制微环境,导致全身肿瘤耐受。
带回家的信息
转化生长因子-β信号在前列腺癌中是治疗这种疾病的一个有效靶点;然而,任何治疗方案都需要了解转化生长因子-β信号网络的所有方面,否则,由于转化生长因子-β的多效性,可能只会带来有限的临床益处。